Clinical AI Trials Update: Promising Screening Approaches
Lungile GABUZA
Cancer du sein de la femme âgée, le point de vue du chirurgien
Didier Bourgeois
Chirurgien cancérologue spécialisé en sénologie et gynécologie
à l’Institut du Sein Henri Hartmann, Neuilly Sur Seine, France
What is the significance of HER2 amplification and how does it affect the use of antibody-drug conjugates (ADCs)?
Joseph GLIGOROV
oncologist, Paris, France
At what stage do you integrate liquid biopsy into breast cancer management? How early?
Simon NAYLER
pathologist, Johanesburgh, South Africa
The difficulty of the radiologist in cancer announcement
Veronique BOUTE
Radiologist, Lisieux, France